Biodistribution of Site-Specific PEGylated Fibroblast Growth Factor-2.

Fibroblast growth factor 2 (FGF-2) is a small 18 kDa protein with clinical potential for ischemic heart disease, wound healing, and spinal cord injury. However, the therapeutic potential of systemic FGF-2 administration is challenged by its fast elimination. Therefore, we deployed genetic codon expansion to integrate an azide functionality to the FGF-2 N-terminus, which was site-directly decorated with poly(ethylene glycol) (PEG) through bioorthogonal strain-promoted azide-alkyne cycloaddition (SPAAC). PEGylated FGF-2 was as bioactive as wild-type FGF-2 as demonstrated by cell proliferation and Erk phosphorylation of fibroblasts. The PEGylated FGF-2 conjugate was radiolabeled with [111In] Indium cation ([111In]In3+) to study its biodistribution through noninvasive imaging by single-photon emission computed tomography (SPECT) and by quantitative activity analysis of the respective organs in healthy mice. This study details the biodistribution pattern of site-specific PEGylated FGF-2 in tissues after intravenous (iv) administration compared to the unconjugated protein. Low accumulation of the PEGylated FGF-2 variant in the kidney and the liver was demonstrated, whereas specific uptake of PEGylated FGF-2 into the retina was significantly diminished. In conclusion, site-specific PEGylation of FGF-2 by SPAAC resulted in a superior outcome for the synthesis yield and in conjugates with excellent biological performances with a gain of half-life but reduced tissue access in vivo.

• Publication year

  2020

• Venue

  ACS Biomaterials Science & Engineering

• Publication date

  2020-01-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acsbiomaterials.9b01248PMID 33463203
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Site-Specific Conjugated Insulin-like Growth Factor-I for Anabolic Therapy.

  2018cited by this paper
• Bioorthogonal strategies for site‐directed decoration of biomaterials with therapeutic proteins

  2018cited by this paper
• Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry.

  2018cited by this paper
• Bioresponsive release of insulin‐like growth factor‐I from its PEGylated conjugate

  2018cited by this paper
• FGF Family: From Drug Development to Clinical Application

  2018cited by this paper
• Site-Specific POxylation of Interleukin-4.

  2017cited by this paper
• Nanomechanics on FGF-2 and Heparin Reveal Slip Bond Characteristics with pH Dependency.

  2017cited by this paper
• Radiolabeled 111In-FGF-2 Is Suitable for In Vitro/Ex Vivo Evaluations and In Vivo Imaging.

  2017cited by this paper
• Probing unnatural amino acid integration into enhanced green fluorescent protein by genetic code expansion with a high-throughput screening platform

  2016cited by this paper
• Interleukin‐4‐Clicked Surfaces Drive M2 Macrophage Polarization

  2016cited by this paper
• Biocompatible Azide–Alkyne “Click” Reactions for Surface Decoration of Glyco‐Engineered Cells

  2016cited by this paper
• Anti-PEG immunity: emergence, characteristics, and unaddressed questions.

  2015cited by this paper
• Bio-orthogonal Immobilization of Fibroblast Growth Factor 2 for Spatial Controlled Cell Proliferation.

  2015cited by this paper
• Decoration of silk fibroin by click chemistry for biomedical application.

  2014cited by this paper
• The role of FGF2 in spinal cord trauma and regeneration research

  2014cited by this paper
• Insulin-like growth factor-I aerosol formulations for pulmonary delivery.

  2013cited by this paper
• Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1.

  2013cited by this paper
• Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-sepharose column.

  2012cited by this paper
• Reprogramming the genetic code

  2012cited by this paper
• Functional context, biosynthesis, and genetic encoding of pyrrolysine.

  2011cited by this paper
• Synthesis of diverse N,O-bridged calix[1]arene[4]pyridine-C(60) dyads and triads and formation of intramolecular self-inclusion complexes.

  2010cited by this paper
• Genetic encoding and labeling of aliphatic azides and alkynes in recombinant proteins via a pyrrolysyl-tRNA Synthetase/tRNA(CUA) pair and click chemistry.

  2009cited by this paper
• Biopolymer-Based Growth Factor Delivery for Tissue Repair: From Natural Concepts to Engineered Systems

  2009cited by this paper
• Temporally Expressed PDGF and FGF-2 Regulate Embryonic Coronary Artery Formation and Growth

  2008cited by this paper
• Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF‐2)

  2003cited by this paper
• Pharmacokinetics and Pharmacodynamics of Recombinant FGF‐2 in a Phase I Trial in Coronary Artery Disease

  2001cited by this paper
• The Amber Codon in the Gene Encoding the Monomethylamine Methyltransferase Isolated from Methanosarcina barkeri Is Translated as a Sense Codon*

  2001cited by this paper
• Clinical applications of angiogenic growth factors and their inhibitors

  1999cited by this paper
• Biological roles of fibroblast growth factor-2.

  1997cited by this paper
• X-ray structure of the 154-amino-acid form of recombinant human basic fibroblast growth factor. comparison with the truncated 146-amino-acid form.

  1997cited by this paper
• Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution.

  1997cited by this paper
• Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis.

  1994cited by this paper
• A general method for site-specific incorporation of unnatural amino acids into proteins.

  1989cited by this paper
• Multiple forms of basic fibroblast growth factor: amino-terminal cleavages by tumor cell- and brain cell-derived acid proteinases.

  1987cited by this paper
• Structural characterization and biological functions of fibroblast growth factor.

  1987cited by this paper
• Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture.

  1986cited by this paper
• Purification of a fibroblast growth factor from bovine pituitary.

  1975cited by this paper
• Mitogenic effect of fibroblast growth factor on early passage cultures of human and murine fibroblasts

  1975cited by this paper

• Deciphering Polymer Interactions in Bioconjugates with Different Architectures by Structural Analysis via Time-resolved Limited Proteolysis Mass Spectrometry.

  2025cites this paper
• Material surface conjugated with fibroblast growth factor-2 for pluripotent stem cell culture and differentiation

  2025cites this paper
• Exploring the impact of inflammatory cytokines on alcoholic liver disease: a Mendelian randomization study with bioinformatics insights into potential biological mechanisms

  2024cites this paper
• Click Chemistry and Radiochemistry: An Update

  2023cites this paper
• Layer-by-layer assembly of poly-l-lysine/hyaluronic acid protein reservoirs on poly(glycerol sebacate) surfaces.

  2023cites this paper
• Matrix Metalloproteinase-Responsive Delivery of PEGylated Fibroblast Growth Factor 2.

  2023cites this paper
• PEGylation of anti-MerTK Antibody Modulates Ocular Biodistribution.

  2022cites this paper
• PEtOxylated Interferon-α2a Bioconjugates Addressing H1N1 Influenza A Virus Infection.

  2022cites this paper
• Biological macromolecules for growth factor delivery

  2022cites this paper
• Bioconjugation strategies and clinical implications of Interferon-bioconjugates.

  2022cites this paper
• Polymer selection impacts the pharmaceutical profile of site-specifically conjugated Interferon-α2a.

  2022cites this paper
• Polyphenol-Coordinated Supramolecular Hydrogel as a Promising “One-Stop-Shop” Strategy for Acute Infected Wound Treatment

  2022cites this paper
• Fibrin Sealants: Challenges and Solutions.

  2022cites this paper
• Protein Engineering Strategies for Improved Pharmacokinetics

  2021cites this paper
• Molecular Insights into Site-Specific Interferon-α2a Bioconjugates Originated from PEG, LPG, and PEtOx.

  2021cites this paper
• Natural Polymeric-Based Composites for Delivery of Growth Factors

  2021cites this paper